Vita 34 Liabilities 2024

Vita 34 Aktienanalyse

What does Vita 34 do?

Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Vita 34's Liabilities

Vita 34's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Vita 34's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Vita 34's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Vita 34's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Vita 34’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Vita 34 stock

What is the level of liabilities of Vita 34 this year?

Vita 34 has a debt balance of 134.8 M EUR this year.

What were the liabilities of Vita 34 compared to the previous year?

The liabilities of Vita 34 have increased by -0.16% dropped compared to the previous year.

What are the consequences of high debt for investors of Vita 34?

High liabilities can pose a risk for investors of Vita 34, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Vita 34?

Low liabilities mean that Vita 34 has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Vita 34 affect the company?

An increase in liabilities of Vita 34 can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Vita 34 affect the company?

A decrease in the liabilities of Vita 34 can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Vita 34?

Some factors that can influence the liabilities of Vita 34 include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Vita 34 so important for investors?

The liabilities of Vita 34 are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Vita 34 take to modify the liabilities?

To change its liabilities, Vita 34 can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Vita 34 pay?

Over the past 12 months, Vita 34 paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 3.85 %. For the coming 12 months, Vita 34 is expected to pay a dividend of -0.02 EUR.

What is the dividend yield of Vita 34?

The current dividend yield of Vita 34 is 3.85 %.

When does Vita 34 pay dividends?

Vita 34 pays a quarterly dividend. This is distributed in the months of September, July, June, July.

How secure is the dividend of Vita 34?

Vita 34 paid dividends every year for the past 0 years.

What is the dividend of Vita 34?

For the upcoming 12 months, dividends amounting to -0.02 EUR are expected. This corresponds to a dividend yield of -0.44 %.

In which sector is Vita 34 located?

Vita 34 is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vita 34 from 6/7/2019 amounting to 0.16 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2019.

When did Vita 34 pay the last dividend?

The last dividend was paid out on 6/7/2019.

What was the dividend of Vita 34 in the year 2023?

In the year 2023, Vita 34 distributed 0 EUR as dividends.

In which currency does Vita 34 pay out the dividend?

The dividends of Vita 34 are distributed in EUR.